Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A1 | P30531 | 2/20 | 0.33 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6277830 | 1.00 | SLC6A1 (0.33) | SLC6A1SLC6A11TP53NPC1ALDH1A1 | |
| SCHEMBL169480 | 0.90 | EGFR (0.35) | SLC6A1SLC6A11NPC1ALDH1A1 | |
| SCHEMBL169481 | 0.90 | EGFR (0.35) | SLC6A1SLC6A11NPC1ALDH1A1 | |
| SCHEMBL132699 | 0.83 | SLC6A11 (0.38) | SLC6A1SLC6A11TP53LMNAHTT | |
| SCHEMBL135522 | 0.82 | SLC6A11 (0.35) | SLC6A1SLC6A11TP53LMNA | |
| SCHEMBL134065 | 0.78 | — | — | |
| SCHEMBL134066 | 0.78 | — | — | |
| SCHEMBL169678 | 0.75 | SLC5A2 (0.36) | SLC6A1SLC6A11LMNAMAPTHTT | |
| SCHEMBL169679 | 0.75 | SLC5A2 (0.36) | SLC6A1SLC6A11LMNAMAPTHTT | |
| SCHEMBL6880054 | 0.75 | SLC5A2 (0.36) | SLC6A1SLC6A11LMNAMAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9464106-B2 | Oligonucleotides useful for detecting and analyzing nucleic acids of interest | EXIQON A/S (DK) | 2016-10-11 | — | — | US | disclosed |
| US-20120157333-A1 | OLIGONUCLEOTIDES USEFUL FOR DETECTING AND ANALYZING NUCLEIC ACIDS OF INTEREST | EXIQON A/S (DK) | 2012-06-21 | — | — | US | disclosed |
| EP-1446412-B1 | NOVEL LNA COMPOSITIONS AND USES THEREOF | EXIQON AS (DK) | 2012-03-07 | — | — | EP | disclosed |
| US-20070117144-A1 | Oligonucleotides useful for detecting and analyzing nucleic acids of interest | EXIQON A/S (DK) | 2007-05-24 | — | — | US | disclosed |
| US-7060809-B2 | LNA compositions and uses thereof | EXIQON A/S (DE) | 2006-06-13 | — | — | US | disclosed |
| US-20030224377-A1 | Novel LNA compositions and uses thereof | QIAGEN GMBH (DE) | 2003-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030224377-A1 | Novel LNA compositions and uses thereof | RNGTT, NCL, NSUN2 | SLC6A1 2880/4885SLC6A11 2707/4885TP53 613/4885 |
| US-20120157333-A1 | OLIGONUCLEOTIDES USEFUL FOR DETECTING AND ANALYZING NUCLEIC ACIDS OF INTEREST | UPF1, DCLRE1B, SNRPA1 | SLC6A1 4477/4885SLC6A11 4253/4885TP53 103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.